High MTHFR promoter methylation levels in men confer protection against ischemic stroke
Open Access
- 2 November 2020
- journal article
- research article
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 20 (4) , 477-486
Abstract
The MTHFR gene encodes methylenetetrahydrofolate reductase required for the metabolism of homocysteine (Hcy) – a previously reported independent risk factor for ischemic stroke (IS). In this study, we first aimed to clarify the association between DNA methylation levels in the MTHFR promoter and the risk of IS, followed by the analysis of potential interactions between environmental factors and DNA methylation levels that affect IS risk. We recruited 164 patients with hypertension and IS (case group) and 345 age-matched and sex-matched patients with hypertension only (control group). Demographic and clinical information was obtained using questionnaires, and blood samples were collected for biochemical analyses. Fluorescence quantitative methylation-specific PCR (qMSP) was used to detect MTHFR promoter methylation levels. A logistic regression analysis was performed to determine the relationship between environmental factors, MTHFR promoter methylation levels, and IS risk. We finally generated a receiver operating characteristic curve to determine whether MTHFR promoter methylation levels can predict IS. The mean MTHFR methylation levels in the case group (8.10 ± 6.14) were significantly lower than those in the control group (17.44 ± 3.16; p < 0.05). MTHFR promoter methylation levels were also lower in patients with plasma Hcy levels ≥15 μmol/L (10.65 ± 4.05) than in those with Hcy levels <15 μmol/L (16.74 ± 4.26, p < 0.001). Finally, we found that MTHFR hypermethylation is a protective factor for IS, particular in men (OR in men: 0.07; 95% CI: 0.02–0.16; p < 0.001). Further, sex and MTHFR promoter methylation levels exhibited a preliminary interaction effect on IS risk. These results indicate that MTHFR promoter methylation status might have diagnostic value in IS.Keywords
This publication has 30 references indexed in Scilit:
- Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patientsEuropean Journal of Internal Medicine, 2014
- The early‐life social environment and DNA methylationClinical Genetics, 2012
- Global DNA methylation and risk of subclinical atherosclerosis in young adults: The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) studyAtherosclerosis, 2011
- Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral bloodHuman Molecular Genetics, 2011
- Sex hormone control of left ventricular structure/function: mechanistic insights using echocardiography, expression, and DNA methylation analyses in adult miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Genetic and environmental determinants of plasma total homocysteine levelsPharmacogenetics and Genomics, 2011
- Ischemic Heart Disease and Stroke in Relation to Blood DNA MethylationEpidemiology, 2010
- Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: A nationwide studyJournal of the Neurological Sciences, 2010
- Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiationMolecular Cancer, 2010
- Some norms and reliability data for the State‐Trait Anxiety Inventory and the Zung Self‐Rating Depression scaleBritish Journal of Clinical Psychology, 1983